Across all ages, AOMs are projected to reverse the increasing obesity trend anticipated in the baseline (without AOMs) scenario, with most ages seeing projected obesity rates in 2045 lower than the estimated obesity rate in 2025
Users stepping into this range should establish tolerance gradually
None of these signs mean you are failing
The STEP UP trial, a Phase 3b study published in The Lancet Diabetes & Endocrinology in 2025, evaluated a 7.2 mg weekly injection dose in over 1,400 adults with obesity (BMI of 30 or higher) and without diabetes
The third option is the most interesting from a biological standpoint: you get the collagen stimulation of retinol on some days and the regenerative signaling (plus barrier repair) of copper peptide on others
In a healthy system, intracellular glutathione immediately neutralizes these free radicals, protecting the delicate mitochondrial membranes from lipid peroxidation and structural damage